Tresiba 3ML 100U/ML

Tresiba (insulin degludec) is a long-acting insulin analog primarily used to treat diabetes mellitus. Here are its primary uses:

1. Type 1 Diabetes: Tresiba is used in individuals with type 1 diabetes to help regulate blood sugar levels. People with type 1 diabetes do not produce insulin, so they require insulin therapy to survive.

2.  

3. Type 2 Diabetes: It is also used in some cases of type 2 diabetes, particularly when other diabetes medications, diet, and exercise have not been sufficient in controlling blood sugar levels. It may be used alone or in combination with other diabetes medications.

4.  

5. Basal Insulin: Tresiba is classified as a long-acting or basal insulin. Basal insulin provides a consistent level of insulin throughout the day and night, helping to maintain stable blood sugar levels between meals and overnight.

6.  

7. Glycemic Control: The primary goal of using Tresiba is to achieve and maintain good glycemic control, which means keeping blood sugar levels within a target range to reduce the risk of complications associated with diabetes, such as cardiovascular problems, kidney disease, and nerve damage.

8.  

9. Flexible Dosing: Tresiba is known for its long duration of action, allowing for flexibility in dosing. It can be taken at any time of day, although it is typically taken once daily at the same time. This flexibility can be helpful for individuals with varying daily routines.

10.  

11. Reducing Hypoglycemia: Tresiba is associated with a lower risk of hypoglycemia (low blood sugar) compared to some other insulins. This can be particularly important for individuals who are at risk of severe hypoglycemic episodes.

12.  

Tresiba (insulin degludec) offers several benefits for individuals with diabetes. These benefits include:

1. Long-Lasting Action: Tresiba is a long-acting insulin with a duration of action that can extend beyond 42 hours. This long duration of action provides a steady and consistent release of insulin, helping to maintain stable blood sugar levels over an extended period.

2.  

3. Reduced Risk of Hypoglycemia: Tresiba is associated with a lower risk of hypoglycemia (low blood sugar) compared to some other insulins. This can be particularly beneficial for individuals who are prone to hypoglycemic episodes or who want to minimize the risk of low blood sugar events.

4.  

5. Flexible Dosing: Tresiba offers flexibility in dosing. It can be taken at any time of day, although it is typically administered once daily at the same time. This flexibility can be convenient for individuals with varying daily routines and lifestyles.

6.  

7. Improved Blood Sugar Control: By providing a consistent basal insulin supply, Tresiba helps individuals achieve better glycemic control. Stable blood sugar levels can reduce the risk of both short-term and long-term complications associated with diabetes.

8.  

9. Lower A1c Levels: Tresiba use can lead to lower A1c levels, which is a measure of average blood sugar control over several months. Lower A1c levels are associated with a reduced risk of diabetes-related complications.

10.  

11. Reduced Need for Frequent Injections: Because of its long-acting nature, Tresiba may require fewer injections per day compared to shorter-acting insulins. This can be more convenient and less intrusive for individuals who need insulin therapy.

12.  

13. Improved Quality of Life: Better blood sugar control and reduced risk of hypoglycemia can contribute to an improved overall quality of life for individuals with diabetes. Stable blood sugar levels can lead to increased energy, better mood, and reduced diabetes-related stress.

Tresiba (insulin degludec) is generally well-tolerated, but like all medications, it can have side effects. Not everyone will experience these side effects, and some people may experience them to varying degrees of severity. Common side effects of Tresiba include:

1. Hypoglycemia: Low blood sugar (hypoglycemia) is the most common side effect of insulin therapy, including Tresiba. Symptoms of hypoglycemia can include shakiness, sweating, rapid heartbeat, confusion, dizziness, and headache.

2.  

3. Injection Site Reactions: Some individuals may experience redness, swelling, or itching at the injection site. These reactions are typically mild and tend to resolve on their own.

4.  

5. Weight Gain: Insulin therapy can lead to weight gain for some people. This is because insulin promotes the storage of glucose and can lead to increased fat storage.

6.  

7. Allergic Reactions: Although rare, some people may have an allergic reaction to Tresiba. Signs of an allergic reaction can include itching, rash, swelling, severe dizziness, and difficulty breathing.

8.  

9. Lipodystrophy: Prolonged use of insulin at the same injection site may lead to fat tissue changes, such as thickening or thinning of the skin. This is known as lipodystrophy.

10.  

11. Fluid Retention: Insulin therapy can sometimes lead to fluid retention, which may result in swelling in the hands or feet.

Tresiba is typically injected once daily, although the specific dosing schedule may vary depending on your healthcare provider's recommendations.

Tresiba (insulin degludec) works by replacing or supplementing the insulin that your body would naturally produce if you didn't have diabetes. Here's how it works:

1. Regulating Blood Sugar: Insulin is a hormone produced by the pancreas that plays a crucial role in regulating blood sugar (glucose) levels in your body. It allows glucose to enter your cells, where it can be used for energy. When you have diabetes, your body either doesn't produce enough insulin (in the case of type 1 diabetes) or doesn't use it effectively (in the case of type 2 diabetes). This leads to elevated blood sugar levels.

2. Long-Acting Basal Insulin: Tresiba is a long-acting basal insulin, which means it provides a slow, steady release of insulin into your bloodstream over an extended period. It mimics the basal insulin production of the pancreas, which helps to maintain stable blood sugar levels between meals and overnight.

3. Lowering Blood Sugar: When you inject Tresiba under your skin, it begins to work gradually and continues to lower blood sugar for an extended period, often lasting beyond 24 hours. This helps prevent spikes in blood sugar levels after meals and keeps your glucose levels within a target range.

4. Combined with Mealtime Insulin: Some individuals with diabetes may also use short-acting or rapid-acting insulins at mealtime to cover the increase in blood sugar that occurs after eating. These mealtime insulins work more quickly and are used in addition to a basal insulin like Tresiba.

If you remember within a few hours of your regular dosing time, take the missed dose as soon as you remember.